ADC Therapeutics SA (NYSE:ADCT) Q2 2023 Earnings Call Transcript August 8, 2023
ADC Therapeutics SA misses on earnings expectations. Reported EPS is $-0.58 EPS, expectations were $0.44.
Operator: Hello, and welcome to the ADC Therapeutics Second Quarter 2023 Financial Results Conference Call. My name is Corey, and I’ll be your operator for today’s call. [Operator Instructions] Please be advised that today’s conference call is being recorded. I would now like to turn the call over to Eugenia...
